A- A A+
Last Updated : Oct 30 2020 1:22PM     Screen Reader Access
News Highlights
PM Modi inaugurates Arogya Van at Kevadia in Gujarat            Finance Ministry extends I-T exemption under LTC cash voucher scheme to non-central government employees            EAM S Jaishankar stresses need for diversification & resilience of supply chain in post-Covid world            Pakistan Minister admits Islamabad's role in Pulwama terror attack            US economy registers record growth of 33 % in third quarter of current fiscal           

National News

Jul 07, 2020
1:50PM

Registration for human trials of Indian vaccine for Coronavirus begins today

@ICMRDELHI
Indian COVID 19 vaccines are in the global race to end the coronavirus pandemic. Indian Council of Medical Research (ICMR) had written to 12 Medical Institutes in the country to start the first phase of Human Clinical Trials by registering volunteers. Our Correspondent has reported that a maximum number of these Institutes have begun the subject enrolment process which was slated to be initiated today. ICMR has partnered with Bharat Biotech International Limited to develop COVAXIN, whereas Zydus Cadila is working on ZyCov-D Vaccine.

Drug Controller General of India recently gave nod to the human trial for both COVAXIN and ZyCov-D vaccines marking the beginning of an end to the global pandemic. Indian manufacturers account for 60 percent of vaccine supplies made to UNICEF. Across the world, more than 140 candidate vaccines are under various stages of development. Indian institutions have also engaged in Research and Development for the development of vaccines in India. With the beginning of enrollment of volunteers today, the two Indian vaccine candidates will now be tested on 1,125 healthy volunteers in the two phases of trials. The vaccines will be evaluated for its safety, reactogenicity, tolerability and immunogenicity. Volunteers will be administered two intramuscular shots. The proposed age groups for the trials are 18-55 years for Phase I and 12-65 years for Phase II. Anand Chaturvedi, AIR News, Delhi.

Dr. Rakesh Mishra, Director of Centre for Cellular and Molecular Biology, Hyderabad has urged people not to lower their guards amidst the scientific progress on vaccine development. Speaking exclusively to AIR News, Dr. Misha lauded the preemptive and timely approach of the government which he said, provided the required impetus for the scientific development in the country.

Live Twitter Feed

Listen News

Morning News 30 (Oct) Midday News 29 (Oct) Evening News 29 (Oct) Hourly 30 (Oct) (1200hrs)
समाचार प्रभात 30 (Oct) दोपहर समाचार 29 (Oct) समाचार संध्या 29 (Oct) प्रति घंटा समाचार 30 (Oct) (1210hrs)
Khabarnama (Mor) 30 (Oct) Khabrein(Day) 29 (Oct) Khabrein(Eve) 29 (Oct)
Aaj Savere 30 (Oct) Parikrama 29 (Oct)

Listen Programs

Market Mantra 29 (Oct) Samayki 9 (Aug) Sports Scan 29 (Oct) Spotlight/News Analysis 29 (Oct) Employment News 29 (Oct) World News 29 (Oct) Samachar Darshan 22 (Mar) Radio Newsreel 21 (Mar)
    Public Speak

    Country wide 12 (Mar) Surkhiyon Mein 29 (Oct) Charcha Ka Vishai Ha 11 (Mar) Vaad-Samvaad 17 (Mar) Money Talk 17 (Mar) Current Affairs 6 (Mar) Sanskrit Saptahiki 24 (Oct) North East Diary 29 (Oct)